Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Ultrasound Device Significantly Reduces Pain in Chronic Pelvic and Interstitial Cystitis Pain Patients–Clinical Study Presented to IPPS Extends Earlier Findings
  • USA - English


News provided by

International Adhesions Society

Oct 15, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dawn, Aurora, CO; 49-year-old PainShield User, Adhesions Patient with Severe Pelvic Pain for Over 10 Years
Dawn, Aurora, CO; 49-year-old PainShield User, Adhesions Patient with Severe Pelvic Pain for Over 10 Years

I LOVE my PainShield. Before I received my miracle machine, I spent the majority of my day lying down.

Post this

Chicago, IL (PRWEB) October 15, 2013 -- A clinical follow-up study to be presented at the International Pelvic Pain Society Annual Meeting in Orlando (Oct. 17-19, 2013) found significant reduction in pain and related symptoms in women who had previously suffered from long-standing, difficult-to-treat chronic pelvic pain, interstitial cystitis, adhesions and endometriosis. This study followed 16 women who were treated with the PainShield® MD Therapeutic Ultrasound device for up to 541 days, confirming and extending the findings of a previous report which followed these women, as well as three men for 207 days.

This latest study found that the PainShield® MD Therapeutic Ultrasound device produced clinically significant reductions in a variety of pain scores, including chronic pelvic and abdominal pain, bladder pain when urinating (dysuria), and muscle and joint pain. The device also significantly reduced the number of painful urination episodes, particularly at night-time, pain related to intercourse (dyspareunia), sacroiliac joint pain, and painful bowel movements. The study findings also include anecdotal reports of clinically significant reductions in pain medication usage, including opioids, and the resulting cost savings, as well as improvements in sleep due to less pain.

Fifteen out of sixteen patients rated their response to the treatment with PainShield MD as “Good” (9/16), “Moderate” (2/16) or “Mild” (4/16), with only one patient reporting a negative response with rapid onset of pain (within one day), which subsided rapidly with discontinuation of therapy. This patient reported similar reaction to conventional, office-based ultrasound previously.

Since the introduction of the PainShield MD, many users have reported significant improvements in their quality of life due to reduced pain, better sleep, weight loss from improved activity levels, reduced medication expenses, and fewer detrimental drug side-effects, such as constipation, due to lower medication consumption. One such patient, Dawn, 49, from Aurora, CO, a mother and grandmother of four, reports: “I LOVE my PainShield. Before I received my miracle machine, I spent the majority of my day lying down. I have had my PainShield MD since December 2012 and usually place it on my lower abdomen. I move it around based upon where the pain is located. I really like the flexibility of being able to place it where I need it most.” Dawn has resumed activities like walks with her husband, cooking and spending time outdoors with her grandchildren – all previously impossible due to the debilitating pain she has suffered for over ten years from adhesions that followed a burst appendix and multiple GYN surgeries.

The PainShield MD clinical study resulted from a grassroots effort under the leadership of a patient advocacy organization, the International Adhesions Society (IAS), which provides information, support and advocacy to patients and their families suffering from adhesion related disorder (ARD). Authoring the study together with Dr. Wiseman was Ms. Teena Petree, PT of Summit Physical Therapy, Dallas, TX, whose specialties include pelvic floor dysfunction and pelvic pain relief.

The International Adhesions Society was founded by David Wiseman, PhD who remarked, “after conducting research on adhesions and pelvic pain and working with patients suffering from these conditions for over 25 years, I feel that this treatment modality can revolutionize the management of pain in the chronic pelvic pain population without the risks of surgery or drugs." Added Wiseman, “The results in the original PainShield MD study were so impressive that I felt compelled to start a company, KevMed, to make this technology widely available to patients in the US. Together with nearly a year of impressive results from actual market experience, these latest study results confirm our earlier conclusion that PainShield MD is a ‘game changer’ in the treatment of chronic pelvic and abdominal pain. We are now planning a larger study to obtain the necessary data to secure insurance reimbursement, a vital next step in making the technology available to millions of pain patients.”

About KevMed

KevMed LLC is a medical company dedicated to the relief of chronic pelvic pain and related disorders. KevMed markets PainShield® MD, a wearable therapeutic ultrasound device as a non-invasive, low-risk treatment modality for chronic pelvic pain and pain associated with related conditions. PainShield MD is available by prescription to patients in the United States and was developed by NanoVibronix of Melville, New York, based on its proprietary technology which miniaturizes the ultrasound delivery system to a small disc mounted within an adhesive patch applied to the skin. NanoVibronix provided the PainShield MD units for the study free of charge.

For more information, contact:
David Wiseman, PhD
International Adhesions Society
18208 Preston Road, Suite D9
PMB 405, Dallas TX 75248
http://www.adhesions.org

KevMed, LLC.
15305 Dallas Parkway, Suite 300
Addison, TX 75001
http://www.kevmed.com

David Wiseman, PhD, International Adhesions Society, http://www.adhesions.org, +1 (972) 931-5596, [email protected]

Modal title

PainShield MD Therapeutic Ultrasound
PainShield MD Therapeutic Ultrasound
International Adhesions Society (IAS)
International Adhesions Society (IAS)
PainShield MD  Follow-Up Study Oct 2013
PainShield MD Follow-Up Study Oct 2013
PainShield MD Therapeutic Ultrasound International Adhesions Society (IAS) PainShield MD  Follow-Up Study Oct 2013

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.